TherapeuticsMD Price to Sales Ratio 2012-2025 | TXMD

Historical PS ratio values for TherapeuticsMD (TXMD) over the last 10 years. The current P/S ratio for TherapeuticsMD as of February 16, 2026 is .
TherapeuticsMD P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2026-02-17 2.30 9.51
2025-09-30 1.08 $0.24 4.47
2025-06-30 1.16 $0.22 5.24
2025-03-31 0.93 $0.16 5.83
2024-12-31 0.86 $0.15 5.63
2024-09-30 1.66 $0.14 11.61
2024-06-30 1.61 $0.09 17.78
2024-03-31 2.29 $0.11 20.26
2023-12-31 2.25 $0.13 17.50
2023-09-30 3.02 $7.40 0.41
2023-06-30 4.12 $7.44 0.55
2023-03-31 3.75 $7.44 0.50
2022-12-31 5.59 $7.48 0.75
2022-09-30 6.64 $-8.10 0.00
2022-06-30 9.95 $-5.12 0.00
2022-03-31 19.00 $-2.25 0.00
2021-12-31 18.00 $0.53 33.71
2021-09-30 37.00 $12.88 2.87
2021-06-30 59.50 $13.42 4.43
2021-03-31 67.00 $12.47 5.37
2020-12-31 60.50 $11.87 5.10
2020-09-30 79.00 $11.00 7.18
2020-06-30 62.50 $12.37 5.05
2020-03-31 53.00 $11.66 4.55
2019-12-31 121.00 $10.22 11.84
2019-09-30 181.50 $8.13 22.34
2019-06-30 130.00 $3.97 32.74
2019-03-31 243.50 $3.58 68.03
2018-12-31 190.50 $3.63 52.45
2018-09-30 328.00 $3.50 93.59
2018-06-30 312.00 $3.81 81.99
2018-03-31 243.50 $3.98 61.15
2017-12-31 302.00 $4.12 73.34
2017-09-30 264.50 $4.26 62.11
2017-06-30 263.50 $4.61 57.22
2017-03-31 360.00 $4.68 76.90
2016-12-31 288.50 $4.94 58.41
2016-09-30 340.50 $5.42 62.82
2016-06-30 425.00 $5.48 77.61
2016-03-31 320.00 $5.76 55.58
2015-12-31 518.50 $5.86 88.46
2015-09-30 293.00 $5.66 51.78
2015-06-30 393.00 $5.57 70.57
2015-03-31 302.50 $5.46 55.45
2014-12-31 222.50 $5.06 43.95
2014-09-30 232.00 $4.76 48.71
2014-06-30 221.00 $4.26 51.86
2014-03-31 315.50 $3.77 83.74
2013-12-31 260.50 $3.54 73.64
2013-09-30 146.50 $3.09 47.37
2013-06-30 151.50 $2.76 54.92
2013-03-31 90.00 $2.44 36.90
2012-12-31 155.00 $2.12 73.12
2012-09-30 172.50 $1.90 90.86
2012-06-30 140.00 $1.82 76.92
2012-03-31 120.00 $1.79 67.15
2011-12-31 75.00 $1.80 41.75
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.027B $0.002B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $100.311B 35.03
Takeda Pharmaceutical (TAK) Japan $58.739B 11.54
Zoetis (ZTS) United States $53.462B 19.73
BeOne Medicines - (ONC) Switzerland $37.951B 201.20
Sandoz Group AG (SDZNY) Switzerland $37.721B 0.00
Otsuka Holdings, - (OTSKY) $37.221B 0.00
Daiichi Sankyo, - (DSNKY) Japan $36.542B 0.00
United Therapeutics (UTHR) United States $20.394B 17.95
Shionogi (SGIOY) Japan $19.736B 15.26
Merck (MKKGY) Germany $19.561B 12.06
IPSEN (IPSEY) France $15.077B 0.00
Ionis Pharmaceuticals (IONS) United States $13.055B 0.00
Neurocrine Biosciences (NBIX) United States $12.457B 26.92
Summit Therapeutics (SMMT) United States $11.536B 0.00
Orion OYJ (ORINY) Finland $11.214B 19.47
Madrigal Pharmaceuticals (MDGL) United States $10.554B 0.00
Eisai (ESAIY) $9.636B 0.00
Ono Pharmaceutical (OPHLF) Japan $8.769B 20.98
Stevanato Group S.p.A (STVN) Italy $4.849B 27.14
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.828B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.659B 22.12
Crinetics Pharmaceuticals (CRNX) United States $4.363B 0.00
Indivior Pharmaceuticals (INDV) United States $4.323B 17.64
Corcept Therapeutics (CORT) United States $4.204B 45.42
NewAmsterdam Pharma (NAMS) Netherlands $3.927B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.322B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.990B 9.54
Hypermarcas (HYPMY) Brazil $2.658B 18.24
Dyne Therapeutics (DYN) United States $2.220B 0.00
Guardian Pharmacy Services (GRDN) United States $2.119B 40.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Soleno Therapeutics (SLNO) United States $2.000B 0.00
Ocular Therapeutix (OCUL) United States $1.933B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.876B 22.23
Harrow (HROW) United States $1.766B 108.39
Ardelyx (ARDX) United States $1.669B 0.00
Enliven Therapeutics (ELVN) United States $1.586B 0.00
Oruka Therapeutics (ORKA) United States $1.559B 0.00
Definium Therapeutics (DFTX) United States $1.552B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.551B 0.00
Relay Therapeutics (RLAY) United States $1.548B 0.00
Nektar Therapeutics (NKTR) United States $1.451B 0.00
Collegium Pharmaceutical (COLL) United States $1.447B 7.17
BioCryst Pharmaceuticals (BCRX) United States $1.425B 84.50
Evotec AG (EVO) Germany $1.248B 0.00
Savara (SVRA) United States $1.139B 0.00
Xeris Biopharma Holdings (XERS) United States $1.132B 0.00
Theravance Biopharma (TBPH) United States $0.990B 41.55
Cronos Group (CRON) Canada $0.988B 0.00
Aktis Oncology (AKTS) United States $0.900B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
Xencor (XNCR) United States $0.828B 0.00
Esperion Therapeutics (ESPR) United States $0.820B 0.00
KalVista Pharmaceuticals (KALV) United States $0.754B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.732B 17.31
Bioventus (BVS) United States $0.684B 14.02
Rigel Pharmaceuticals (RIGL) United States $0.623B 5.56
ProKidney (PROK) United States $0.596B 0.00
Lyell Immunopharma (LYEL) United States $0.549B 0.00
4D Molecular Therapeutics (FDMT) United States $0.534B 0.00
Altimmune (ALT) United States $0.511B 0.00
Siga Technologies (SIGA) United States $0.486B 6.66
Zevra Therapeutics (ZVRA) United States $0.479B 0.00
Elite Pharmaceuticals (ELTP) United States $0.474B 0.00
Organogenesis (ORGO) United States $0.473B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 28.03
Lexeo Therapeutics (LXEO) United States $0.461B 0.00
Aquestive Therapeutics (AQST) United States $0.445B 0.00
USANA Health Sciences (USNA) United States $0.382B 10.66
Aclaris Therapeutics (ACRS) United States $0.346B 0.00
Protara Therapeutics (TARA) United States $0.336B 0.00
Akebia Therapeutics (AKBA) United States $0.321B 0.00
Aldeyra Therapeutics (ALDX) United States $0.318B 0.00
Cybin (HELP) Canada $0.304B 0.00
Relmada Therapeutics (RLMD) United States $0.273B 0.00
Minerva Neurosciences (NERV) United States $0.271B 0.00
Avalo Therapeutics (AVTX) United States $0.264B 0.00
Enlivex Therapeutics (ENLV) Israel $0.263B 0.00
Larimar Therapeutics (LRMR) United States $0.261B 0.00
Journey Medical (DERM) United States $0.257B 0.00
OmniAb (OABI) United States $0.245B 0.00
Profound Medical (PROF) Canada $0.240B 0.00
Achieve Life Sciences (ACHV) Canada $0.224B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Context Therapeutics (CNTX) United States $0.211B 0.00
Heron Therapeutics (HRTX) United States $0.211B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Surrozen (SRZN) United States $0.210B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.184B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
AleAnna (ANNA) United States $0.171B 0.00
Karyopharm Therapeutics (KPTI) United States $0.157B 0.00
Century Therapeutics (IPSC) United States $0.153B 0.00
Prelude Therapeutics (PRLD) United States $0.140B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.133B 0.00
Avita Medical (RCEL) United States $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.105B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Incannex Healthcare (IXHL) Australia $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.084B 35.76
Pyxis Oncology (PYXS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
PolyPid (PYPD) Israel $0.070B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
HST Global (HSTC) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.50
Fractyl Health (GUTS) United States $0.057B 0.00
BioNxt Solutions (BNXTF) Canada $0.057B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.056B 0.00
Dominari Holdings (DOMH) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Acrivon Therapeutics (ACRV) United States $0.051B 0.00
Nutriband (NTRB) United States $0.050B 0.00
Lipocine (LPCN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Lite Strategy (LITS) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
Talphera (TLPH) United States $0.038B 0.00
Telomir Pharmaceuticals (TELO) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
Wellgistics Health (WGRX) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Phio Pharmaceuticals (PHIO) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Liminatus Pharma (LIMN) United States $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Inotiv (NOTV) United States $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Ernexa Therapeutics (ERNA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00